v3.26.3
Commitments and Contingencies (FY) (Details)
$ in Thousands
1 Months Ended 3 Months Ended 6 Months Ended 12 Months Ended
May 07, 2026
USD ($)
Dec. 20, 2019
USD ($)
May 31, 2022
USD ($)
Dec. 31, 2020
USD ($)
Jun. 30, 2026
USD ($)
Jun. 30, 2025
USD ($)
Jun. 30, 2026
USD ($)
Jun. 30, 2025
USD ($)
Dec. 31, 2025
USD ($)
Dec. 31, 2024
USD ($)
Dec. 31, 2018
USD ($)
May 31, 2025
USD ($)
Nov. 30, 2022
USD ($)
Jun. 30, 2021
USD ($)
ft²
Apr. 30, 2019
ft²
Loss Contingencies [Line Items]                              
Sublease income                 $ 0 $ 398          
Cash paid for amounts included in measurement of lease liabilities $ 2,700               2,300 2,500          
Research and development         $ 6,162 $ 13,143 $ 14,343 $ 26,263 $ 44,830 $ 56,434          
Lease commenced in April 2019                              
Loss Contingencies [Line Items]                              
Laboratory and office space to be rented (in Square Feet) | ft²                             9,949
Sublease Agreement, Year One                              
Loss Contingencies [Line Items]                              
Sublease income     $ 2,100                        
Lease commencing June 2021                              
Loss Contingencies [Line Items]                              
Laboratory and office space to be rented (in Square Feet) | ft²                           25,778  
Tenant improvements                           $ 5,700  
Security deposit provided                       $ 700   $ 1,000  
Harpoon | Assignment and License Agreement                              
Loss Contingencies [Line Items]                              
Reimbursable legal costs   $ 75                          
Minimum annual royalties   $ 250                          
Upfront fee paid                     $ 500        
License Agreement, Termination, Prior Written Notice   30 days                          
Adimab | Devolpment and Option Agreement                              
Loss Contingencies [Line Items]                              
Upfront fee paid       $ 100                      
Research and development       100                      
Upfront and final fee       200                      
Exercised option fee       500                 $ 500    
Adimab | Minimum | Devolpment and Option Agreement                              
Loss Contingencies [Line Items]                              
Research program milestone fees       150                 500    
Exercised option milestone fee       1,000                 1,000    
Adimab | Maximum | Devolpment and Option Agreement                              
Loss Contingencies [Line Items]                              
Research program milestone fees       200                 1,500    
Exercised option milestone fee       $ 4,000                 $ 2,000